( MENAFN - EIN Presswire) RENO, NV, UNITED STATES, November 5, 2024 /EINPresswire / -- Cellev8, a leading provider of Superoxide Dismutase (SOD) gummies, and Zyppah, the innovator of patented anti-snoring devices, have joined forces in a groundbreaking collaborative sales agreement. This partnership aims to address the needs of the estimated 90 million Americans affected by snoring, offering a comprehensive solution for better sleep and enhanced recovery. Snoring and Inflammation The impact of snoring-related inflammation can lead to various health issues: Increased risk of cardiovascular diseases, diabetes, and neurodegenerative conditions.
Higher levels of C-reactive protein (CRP), a marker of inflammation, in severe snorers. Potential damage to the endothelial cells lining blood vessels, contributing to cardiovascular problems. Cellev8's Product and Its Potential Benefits Cellev8's Inflammation and Recovery Gummies, containing clinically proven SOD2 and other mega antioxidants, could potentially help the snoring population by: Reducing oxidative stress: SOD is a potent antioxidant that neutralizes superoxide radicals, which are elevated in chronic inflammatory conditions.
Combating inflammation: Our clinically proven SOD2 has shown anti-inflammatory properties in various studies, helping to mitigate inflammatory effects. Supporting overall health: The combination of clinically proven SOD2 and other antioxidants in Cellev8's product may additionally help protect against the.
